Vaxcell Bio Therapeutics
KOSDAQ:323990
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Vaxcell Bio Therapeutics (323990) under the Base Case is 8 680.76 KRW per share. Compared with the current market price of 4 835 KRW, the stock appears Undervalued by 44% .
The intrinsic value is calculated using the DCF method. Net margin recovers from -189% last year to -100% by 2031. Revenue grows about 15% a year over the next five years. The forecast years subtract value, so the estimate rests entirely on the years after 2031.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Vaxcell Bio Therapeutics Does
Vaxcell Bio Therapeutics is a South Korean biotech company focused on cell-based medicines. It develops immune-cell and stem-cell therapies meant to treat serious diseases, especially cancers and other hard-to-treat conditions. In simple terms, it tries to turn living cells into medicines that doctors can use in patients.
- Headquarters
- Korea KR
- Employees
- 47
- IPO date
- Sep 22, 2020
Earnings Waterfall
Vaxcell Bio Therapeutics
What is the Intrinsic Value of one Vaxcell Bio Therapeutics stock?
The intrinsic value for Vaxcell Bio Therapeutics (323990) under the Base Case is 8 680.76 KRW.
Is Vaxcell Bio Therapeutics stock undervalued or overvalued?
Compared with the current market price of 4 835 KRW, the stock appears Undervalued by 44% .